News

Founders Fund and Max Levchin, a PayPal co-founder, led this latest financing along with investment from Schooner Capital. The company also announced the release of its first product:

Lemtrada, a monoclonal antibody that selectively targets CD52, has been approved by ANMAT to treat adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease defined by

The investigational vaccine is being co-developed by GlycoVaxyn AG and Janssen Pharmaceuticals Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The first-in-human clinical study

So far, WILEX has completed many clinical studies with Mesupron in different indications, including two Phase II proof of concept trials for pancreatic cancer and metastatic breast cancer.

Eisai’s E6201 is a dual-targeted FLT3 and MEK inhibitor, which has completed a PhaseI clinical trial showing preliminary antitumor activity and an acceptable safety profile. Building on a

The deal grants Merz an exclusive North American license, with certain additional international rights, for the development and commercialization of BBI-3000, to treat skin conditions known to be

Under the deal, AcipHex Sprinkle will be distributed by FSC Laboratories and promoted by its subsidiary, FSC Pediatrics, to pediatric primary care-focused practitioners across the US. FSC Pediatrics

The data demonstrate that patients who continued Gattex treatment beyond two years achieved clinically meaningful reductions in parenteral support requirements, including volume and days off, with 13 out

"For quite some time, physicians have relied on Cordran® Lotion and Cordran® Cream to help treat a variety of skin conditions. With the launch of Cordran Ointment, physicians